Royal Bank of Canada »

Aileron Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Aileron Therapeutics (ALRN) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Aileron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aileron Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aileron Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-03-31 $239k 36k 6.64
2022-12-31 $0 2 0.00

More positions owned by Royal Bank of Canada

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Tc Energy Corp (TRP)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Enbridge (ENB)
Canadian Natural Resources (CNQ)

View all positions for Royal Bank of Canada

Top funds holding Aileron Therapeutics

Satter Management
Nantahala Capital Management
Geode Capital Management
Sigma Planning
Vanguard Group
Gagnon Securities
Royal Bank of Canada
William Blair $ Company
Texas Capital Bank Wealth Management Services
Citadel Advisors
Tower Research Capital
JFS Wealth Advisors
Us Bancorp
Morgan Stanley
FMR

View all funds holding Aileron Therapeutics